Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Extension Study to Evaluate the Safety and Tolerability of TAK-861 in Participants With Selected Central Hypersomnia Conditions

NCT05816382 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT05816382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05816382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Extension Study to Evaluate the Safety and Tolerability of TAK-861 in Participants With Selected Central Hypersomnia Conditions
Lead sponsor
Takeda
Phase
Phase 2/3
Overall status
Recruiting
Start date
April 5, 2023
Completion date
February 28, 2028
Enrollment
500 (estimated)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

narcolepsy type 1